Literature DB >> 19179471

CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.

Josef Kurtz1, Forum Raval, Casey Vallot, Jayden Der, Megan Sykes.   

Abstract

Although the inhibitory receptor CTLA-4 (CD152) has been implicated in peripheral CD4 T-cell tolerance, its mechanism of action remains poorly defined. We analyzed mechanisms of CD4 cell tolerance in a model of tolerance induction involving establishment of mixed hematopoietic chimerism in recipients of fully MHC-mismatched allogeneic bone marrow cells with anti-CD154 mAb. Animals lacking CD80 and CD86 failed to achieve chimerism. We detected no T cell-intrinsic requirement for CD28 for chimerism induction. However, a CD4 T cell-intrinsic signal through CTLA-4 was shown to be essential within the first 48 hours of exposure to alloantigen for the establishment of tolerance and mixed chimerism. This signal must be provided by a recipient CD80/86(+) non-T-cell population. Donor CD80/86 expression was insufficient to achieve tolerance. Together, our findings demonstrate a surprising role for interactions of CTLA-4 expressed by alloreactive peripheral CD4 T cells with CD80/86 on recipient antigen-presenting cells (APCs) in the induction of early tolerance, suggesting a 3-cell tolerance model involving directly alloreactive CD4 cells, donor antigen-expressing bone marrow cells, and recipient antigen-presenting cells. This tolerance is independent of regulatory T cells and culminates in the deletion of directly alloreactive CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179471      PMCID: PMC2668856          DOI: 10.1182/blood-2008-01-133736

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  75 in total

1.  The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens.

Authors:  Jens Lohr; Birgit Knoechel; Shuwei Jiang; Arlene H Sharpe; Abul K Abbas
Journal:  Nat Immunol       Date:  2003-05-25       Impact factor: 25.606

2.  Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.

Authors:  Qizhi Tang; Kammi J Henriksen; Elisa K Boden; Aaron J Tooley; Jianqin Ye; Sumit K Subudhi; Xin X Zheng; Terry B Strom; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

3.  B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].

Authors:  Patricia A Taylor; Christopher J Lees; Sylvie Fournier; James P Allison; Arlene H Sharpe; Bruce R Blazar
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

4.  CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.

Authors:  Qizhi Tang; Judy A Smith; Greg L Szot; Ping Zhou; Maria-Luisa Alegre; Kammi J Henriksen; Craig B Thompson; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

5.  Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L.

Authors:  Yasuo Takeuchi; Hiroshi Ito; Josef Kurtz; Thomas Wekerle; Leon Ho; Megan Sykes
Journal:  Am J Transplant       Date:  2004-01       Impact factor: 8.086

6.  CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.

Authors:  Xue-Zhong Yu; Michael H Albert; Paul J Martin; Claudio Anasetti
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

7.  Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation.

Authors:  Sergio A Quezada; Bruce Fuller; Lamis Z Jarvinen; Mercedes Gonzalez; Bruce R Blazar; Alexander Y Rudensky; Terry B Strom; Randolph J Noelle
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

8.  Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4 T cells via BMT and anti-CD40L.

Authors:  Josef Kurtz; Ariadne Lie; Mathew Griffith; Shannon Eysaman; Juanita Shaffer; Natalie Anosova; Laurence Turka; Gilles Benichou; Megan Sykes
Journal:  Am J Transplant       Date:  2003-07       Impact factor: 8.086

9.  Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.

Authors:  Josef Kurtz; Juanita Shaffer; Ariadne Lie; Natalie Anosova; Gilles Benichou; Megan Sykes
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

10.  Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.

Authors:  Edward Seung; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more
  18 in total

1.  Layers of regulation in induction of mixed chimerism by anti-CD40L.

Authors:  Carrie L Lucas; Megan Sykes
Journal:  Chimerism       Date:  2011 Oct-Dec

Review 2.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

3.  LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.

Authors:  Carrie L Lucas; Creg J Workman; Semir Beyaz; Samuel LoCascio; Guiling Zhao; Dario A A Vignali; Megan Sykes
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

4.  Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.

Authors:  Jeremy I Pearl; Andrew S Lee; Dennis B Leveson-Gower; Ning Sun; Zhumur Ghosh; Feng Lan; Julia Ransohoff; Robert S Negrin; Mark M Davis; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

Review 5.  Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance.

Authors:  Jose M M Granados; Gilles Benichou; Tatsuo Kawai
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

6.  CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential.

Authors:  Tomoyuki Shimazu; Ryuji Iida; Qingzhao Zhang; Robert S Welner; Kay L Medina; José Alberola-Lla; Paul W Kincade
Journal:  Blood       Date:  2012-02-27       Impact factor: 22.113

7.  Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.

Authors:  Jun Li; Kenrick Semple; Woong-Kyung Suh; Chen Liu; Fangping Chen; Bruce R Blazar; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2011-03-27       Impact factor: 5.742

Review 8.  3G11 expression in CD4+ T cell-mediated autoimmunity and immune tolerance.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Int Immunopharmacol       Date:  2010-11-24       Impact factor: 4.932

9.  Mechanisms of transplantation tolerance in animals and humans.

Authors:  Megan Sykes
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

10.  Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha.

Authors:  Isabelle Bekeredjian-Ding; Meike Schäfer; Evelyn Hartmann; Ralph Pries; Marijo Parcina; Philip Schneider; Thomas Giese; Stefan Endres; Barbara Wollenberg; Gunther Hartmann
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.